Huons Co., Ltd. (KOSDAQ:243070)

South Korea flag South Korea · Delayed Price · Currency is KRW
28,150
+200 (0.72%)
At close: Dec 5, 2025
16.56%
Market Cap 328.00B
Revenue (ttm) 602.21B
Net Income (ttm) 35.75B
Shares Out 11.65M
EPS (ttm) 2,985.83
PE Ratio 9.43
Forward PE n/a
Dividend 630.00 (2.24%)
Ex-Dividend Date Nov 24, 2025
Volume 20,532
Average Volume 31,860
Open 28,300
Previous Close 27,950
Day's Range 27,800 - 28,300
52-Week Range 21,800 - 32,200
Beta 0.07
RSI 46.22
Earnings Date Nov 9, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy... [Read more]

Sector Healthcare
Founded 1965
Employees 912
Stock Exchange KOSDAQ
Ticker Symbol 243070
Full Company Profile

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.

Financial Statements

News

There is no news available yet.